August J. Troendle net worth and biography

August Troendle Biography and Net Worth

Dr. Troendle has been the Chief Executive Officer and Chairman of the Board of Directors of Medpace since he founded the Company in July 1992. Dr. Troendle was also the President of Medpace through July 31, 2021. Before founding Medpace, Dr. Troendle served as Assistant Director, Associate Director and Senior Associate Director from 1987 to 1992 at Sandoz (Novartis), where he was responsible for the clinical development of lipid altering agents. From 1986 to 1987, Dr. Troendle worked as a Medical Review Officer in the Division of Metabolic and Endocrine Drug Products at the FDA. Dr. Troendle also has extensive experience serving as a director for a diverse group of public and private companies, including as a director of Coherus BioSciences, Inc. from 2012 to February 2018, as a director of Xenon Pharmaceuticals Inc. from 2007 to 2008, as a director of LIB Therapeutics, LLC since 2015 and as a director of CinRx Pharma, LLC since 2015. Dr. Troendle received his Medical Degree from the University of Maryland, School of Medicine.

What is August J. Troendle's net worth?: The estimated net worth of August J. Troendle is at least $1.84 billion as of March 8th, 2024. Dr. Troendle owns 4,733,019 shares of Medpace stock worth more than $1,844,788,816 as of April 26th. This net worth approximation does not reflect any other investments that Dr. Troendle may own. Additionally, Dr. Troendle receives an annual salary of $1,680,000.00 as CEO at Medpace. Learn More about August J. Troendle's net worth.
How old is August J. Troendle?: Dr. Troendle is currently 68 years old. There are 5 older executives and no younger executives at Medpace. Learn More on August J. Troendle's age.
What is August J. Troendle's salary?: As the CEO of Medpace Holdings, Inc., Dr. Troendle earns $1,680,000.00 per year. Learn More on August J. Troendle's salary.
How do I contact August J. Troendle?: The corporate mailing address for Dr. Troendle and other Medpace executives is 5375 MEDPACE WAY, CINCINNATI OH, 45227. Medpace can also be reached via phone at (513) 579-9911 and via email at [email protected]. Learn More on August J. Troendle's contact information.
Has August J. Troendle been buying or selling shares of Medpace?: August J. Troendle has not been actively trading shares of Medpace during the last ninety days. Most recently, August J. Troendle sold 25,000 shares of the business's stock in a transaction on Friday, March 8th. The shares were sold at an average price of $408.71, for a transaction totalling $10,217,750.00. Following the completion of the sale, the chief executive officer now directly owns 4,733,019 shares of the company's stock, valued at $1,934,432,195.49. Learn More on August J. Troendle's trading history.
Who are Medpace's active insiders?: Medpace's insider roster includes Kevin Brady (CFO), Susan Burwig (VP), Stephen Ewald (General Counsel), Jesse Geiger (CFO), Ashley Keating (Director), Tom King (Director), Robert Kraft (Director), and August Troendle (CEO). Learn More on Medpace's active insiders.
Are insiders buying or selling shares of Medpace?: In the last twelve months, insiders at the sold shares 24 times. They sold a total of 809,782 shares worth more than $239,436,337.21. The most recent insider tranaction occured on March, 15th when VP Susan E Burwig sold 102 shares worth more than $41,106.00. Insiders at Medpace own 20.3% of the company. Learn More about insider trades at Medpace.
Information on this page was last updated on 3/15/2024.

August J. Troendle Insider Trading History at Medpace

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/8/2024	Sell	25,000	$408.71	$10,217,750.00	4,733,019
3/6/2024	Sell	100,000	$412.98	$41,298,000.00	4,833,019
11/30/2023	Sell	7,871	$272.18	$2,142,328.78	5,613,986
11/28/2023	Sell	21,833	$273.66	$5,974,818.78	5,643,114
11/22/2023	Sell	25,000	$277.81	$6,945,250.00	5,689,947
11/16/2023	Sell	17,000	$281.61	$4,787,370.00	5,839,947
11/14/2023	Sell	25,000	$283.11	$7,077,750.00	5,889,947
9/21/2023	Sell	61,655	$244.27	$15,060,466.85	5,914,947
9/19/2023	Sell	137,379	$259.66	$35,671,831.14	6,042,255
6/8/2023	Sell	49,347	$220.85	$10,898,284.95	6,233,019
4/25/2023	Sell	31,648	$221.83	$7,020,475.84	6,451,371
9/21/2022	Buy	94,119	$161.63	$15,212,453.97	6,425,593
9/15/2022	Buy	62,516	$153.11	$9,571,824.76	6,080,720
9/12/2022	Buy	62,515	$167.58	$10,476,263.70	5,893,172
9/8/2022	Buy	56,557	$157.65	$8,916,211.05	5,774,100
7/18/2022	Buy	8,330	$145.00	$1,207,850.00	5,513,639
7/14/2022	Buy	22,290	$144.59	$3,222,911.10	5,505,309
1/4/2022	Sell	3,338	$213.44	$712,462.72
12/29/2021	Sell	16,750	$220.16	$3,687,680.00
12/27/2021	Sell	39,171	$226.11	$8,856,954.81
12/22/2021	Sell	38,960	$220.50	$8,590,680.00
12/20/2021	Sell	22,734	$212.57	$4,832,566.38
12/17/2021	Sell	30,605	$213.59	$6,536,921.95
12/15/2021	Sell	2,424	$210.28	$509,718.72
12/9/2021	Sell	14,994	$212.13	$3,180,677.22
12/7/2021	Sell	18,520	$211.78	$3,922,165.60
11/29/2021	Sell	12,115	$212.10	$2,569,591.50
11/26/2021	Sell	15,071	$210.99	$3,179,830.29
11/24/2021	Sell	14,578	$213.26	$3,108,904.28
8/31/2021	Sell	12,675	$182.04	$2,307,357.00	706,643
8/5/2021	Sell	556	$180.04	$100,102.24
7/26/2021	Sell	15,209	$181.47	$2,759,977.23
7/23/2021	Sell	18,882	$181.21	$3,421,607.22
7/21/2021	Sell	9,206	$182.42	$1,679,358.52	706,643
7/19/2021	Sell	1,442	$181.11	$261,160.62	6,138,961
7/15/2021	Sell	13,697	$181.88	$2,491,210.36
7/13/2021	Sell	13,050	$182.96	$2,387,628.00	706,643
7/9/2021	Sell	12,597	$183.34	$2,309,533.98
7/7/2021	Sell	4,574	$180.33	$824,829.42	706,643
6/29/2021	Sell	4,926	$181.11	$892,147.86	706,643
6/23/2021	Sell	1,837	$180.79	$332,111.23	706,643
6/21/2021	Sell	9,345	$181.86	$1,699,481.70	706,643
6/18/2021	Sell	1,261	$180.43	$227,522.23	706,643
6/16/2021	Sell	17,413	$181.13	$3,154,016.69	706,643
4/22/2021	Sell	14,377	$188.64	$2,712,077.28	706,643
4/20/2021	Sell	17,623	$182.44	$3,215,140.12	706,643
4/16/2021	Sell	17,528	$180.30	$3,160,298.40	706,643
4/14/2021	Sell	3,720	$180.48	$671,385.60	706,643
1/7/2021	Sell	185,219	$140.06	$25,941,773.14	706,643
12/30/2020	Sell	19,930	$140.01	$2,790,399.30	706,643
12/28/2020	Sell	1,374	$140.00	$192,360.00	706,643
12/23/2020	Sell	3,547	$140.11	$496,970.17	706,643
12/18/2020	Sell	216,048	$141.85	$30,646,408.80	666,643
8/24/2020	Sell	18,903	$123.36	$2,331,874.08	616,643
8/19/2020	Sell	21,614	$127.63	$2,758,594.82	616,643
8/17/2020	Sell	16,485	$128.18	$2,113,047.30	616,643
8/14/2020	Sell	16,857	$127.07	$2,142,018.99	616,643
8/12/2020	Sell	21,916	$127.21	$2,787,934.36	616,643
8/10/2020	Sell	48,148	$120.79	$5,815,796.92	616,643
8/4/2020	Sell	45,488	$124.43	$5,660,071.84	616,643
7/31/2020	Sell	39,622	$118.17	$4,682,131.74	616,643
7/29/2020	Sell	47,106	$123.99	$5,840,672.94	616,643
7/27/2020	Sell	29,019	$110.43	$3,204,568.17	616,643
7/24/2020	Sell	66,123	$108.87	$7,198,811.01	616,643
7/22/2020	Sell	35,878	$109.99	$3,946,221.22	616,643
7/20/2020	Sell	17,735	$105.47	$1,870,510.45	616,643
7/17/2020	Sell	19,309	$105.32	$2,033,623.88	616,643
7/15/2020	Sell	28,700	$104.90	$3,010,630.00	616,643
7/13/2020	Sell	8,582	$100.40	$861,632.80
2/4/2019	Sell	18,920	$66.54	$1,258,936.80	603,702
2/1/2019	Sell	84,093	$65.54	$5,511,455.22	603,702
1/30/2019	Sell	102,828	$63.22	$6,500,786.16	603,702
1/28/2019	Sell	4,221	$61.04	$257,649.84	603,702
1/24/2019	Sell	3,501	$61.14	$214,051.14	603,702
1/22/2019	Sell	9,936	$61.10	$607,089.60	603,702
1/17/2019	Sell	8,760	$61.17	$535,849.20	603,702
1/15/2019	Sell	600	$61.00	$36,600.00	603,702
9/27/2018	Sell	46,778	$58.96	$2,758,030.88	351,851
9/25/2018	Sell	38,640	$58.36	$2,255,030.40	351,851
9/20/2018	Sell	114,983	$59.31	$6,819,641.73	351,851
8/6/2018	Sell	731,460	$59.26	$43,346,319.60	849,621
8/2/2018	Sell	371,795	$59.20	$22,010,264.00	849,621
8/18/2016	Buy	10,000	$27.98	$279,800.00	1,221,416
8/16/2016	Buy	869,565	$23.00	$19,999,995.00	1,221,416

August J. Troendle Buying and Selling Activity at Medpace

Medpace Company Overview

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Today's Range

Now: $389.46

$388.88

$396.09

50 Day Range

MA: $397.75

$372.00

$413.31

2 Week Range

Now: $389.46

$189.30

$421.00

Volume

28,702 shs

Average Volume

249,331 shs

Market Capitalization

$12.07 billion

P/E Ratio

39.70

Dividend Yield

N/A

Beta

1.38

Biden replacement revealed?

From Paradigm Press | Ad

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

See his shocking evidence in this new report

August Troendle Biography and Net Worth

What is August J. Troendle's net worth?

How old is August J. Troendle?

What is August J. Troendle's salary?

How do I contact August J. Troendle?

Has August J. Troendle been buying or selling shares of Medpace?

Who are Medpace's active insiders?

Are insiders buying or selling shares of Medpace?